ETON:US
$15.85
-5.879%

Eton Pharmaceuticals Inc.
News & Events

Last updated: Jun 9, 2025, 10:31 PM ET

  1. Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI(TM) (hydrocortisone) Oral Solution

    GlobeNewswire MAY 28, 2025 5:28 PM EDT
    • KHINDIVI is the first and only FDA-approved hydrocortisone oral solution •...
    READ ARTICLE
  2. Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

    GlobeNewswire MAY 14, 2025 4:30 PM EDT
    DEER PARK, Ill., May 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton”...
    READ ARTICLE
  3. Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

    GlobeNewswire MAY 13, 2025 4:01 PM EDT
    Q1 2025 revenue of $17.3 million, with product sales of $14.0 million, representing 76% growth ov...
    READ ARTICLE
  4. Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

    GlobeNewswire MAY 1, 2025 4:30 PM EDT
    DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton”...
    READ ARTICLE
  5. Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

    GlobeNewswire APR 28, 2025 6:50 AM EDT
    - NDA submitted for the treatment of central diabetes insipidus - - Expected 10-month review; c...
    READ ARTICLE
  6. Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

    GlobeNewswire APR 1, 2025 7:00 AM EDT
    DEER PARK, Ill., April 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Etonȁ...
    READ ARTICLE
  7. Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

    GlobeNewswire MAR 18, 2025 6:50 AM EDT
    Management to Hold Investor Day Conference Call Today at 10:00am ET Reported record product...
    READ ARTICLE
  8. Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

    GlobeNewswire MAR 14, 2025 6:50 AM EDT
    - Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence...
    READ ARTICLE
  9. Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

    GlobeNewswire MAR 4, 2025 6:50 AM EST
    DEER PARK, Ill., March 04, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton ...
    READ ARTICLE
  10. Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

    GlobeNewswire MAR 3, 2025 6:50 AM EST
    – Eton expects to significantly expand patient access to this critical treatment for ...
    READ ARTICLE

Upcoming Events

Get notified of Eton Pharmaceuticals Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement (Unconfirmed)

    Aug 7, 2025
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available